Thiol redox biology of trypanosomatids and potential targets for chemotherapy

Trypanosomatids are the causative agents of African sleeping sickness, Chagas' disease, and the different forms of leishmaniasis. This family of protozoan parasite possesses a trypanothione-based redox metabolism that provides the reducing equivalents for various vital processes such as the bio...

Ausführliche Beschreibung

Gespeichert in:
Bibliographische Detailangaben
Hauptverfasser: Leroux, Alejandro E. (VerfasserIn) , Krauth-Siegel, Renate (VerfasserIn)
Dokumenttyp: Article (Journal)
Sprache:Englisch
Veröffentlicht: 2016
In: Molecular and biochemical parasitology
Year: 2015, Jahrgang: 206, Heft: 1-2, Pages: 67-74
ISSN:1872-9428
DOI:10.1016/j.molbiopara.2015.11.003
Online-Zugang:Resolving-System, lizenzpflichtig, Volltext: https://doi.org/10.1016/j.molbiopara.2015.11.003
Verlag, lizenzpflichtig, Volltext: http://www.sciencedirect.com/science/article/pii/S0166685115300396
Volltext
Verfasserangaben:Alejandro E. Leroux, R. Luise Krauth-Siegel
Beschreibung
Zusammenfassung:Trypanosomatids are the causative agents of African sleeping sickness, Chagas' disease, and the different forms of leishmaniasis. This family of protozoan parasite possesses a trypanothione-based redox metabolism that provides the reducing equivalents for various vital processes such as the biosynthesis of DNA precursors and the detoxification of hydroperoxides. Almost all enzymes of the redox pathway proved to be essential and therefore fulfil one crucial prerequisite for a putative drug target. Trypanothione synthetase and trypanothione reductase are present in all trypanosomatids but absent from the mammalian host which, in addition to the essentiality, renders them highly specific. The chemotherapy research on both enzymes is further supported by the availability of high-throughput screening techniques and crystal structures. In this review we focus on the recent advances and limitations in the development of lead compounds targeting trypanothione synthetase and trypanothione reductase. We present an overview of the available inhibitors and discuss future perspectives including other components of the parasite-specific redox pathway.
Beschreibung:Available online 22 November 2015
Gesehen am 18.06.2020
Beschreibung:Online Resource
ISSN:1872-9428
DOI:10.1016/j.molbiopara.2015.11.003